Barclays lowered the firm’s price target on Molina Healthcare (MOH) to $339 from $372 and keeps an Equal Weight rating on the shares. The company reported a Q4 earnings miss with pressure across Medicaid, Medicare and Marketplace, the analyst tells investors in a research note.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Molina Healthcare Reports Strong 2024 Earnings Growth
- Molina Healthcare’s Earnings Call: Growth Amid Challenges
- White House readying order to fire thousands of federal health workers, WSJ says
- Closing Bell Movers: Semis down sharply after results
- Molina Healthcare reports Q4 adjusted EPS $5.05, consensus $5.88